We are live on ! Find out more
MITO

Stealth BioTherapeutics Corp. ADS
MITO

Delisted

MITO was delisted on the 15th of November, 2022.

Back to rankings

13 hedge funds and large institutions have $3.9M invested in Stealth BioTherapeutics Corp. ADS in 2021 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more capital invested

Capital invested by funds: $1.46M → $3.9M (+$2.44M)

0% more funds holding

Funds holding: 13 → 13 (0)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

Holders
13
Holders Change
–
Holders Change %
0%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
6
Reduced
–
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
+$1.29M
2
Renaissance Technologies
Renaissance Technologies
New York
+$538K
3
SM
Sabby Management
Florida
+$518K
4
BFM
Boothbay Fund Management
New York
+$161K
5
Citadel Advisors
Citadel Advisors
Florida
+$135K

Top Sellers

Rank Fund Capital Flow
1
Mercer Global Advisors
Mercer Global Advisors
Colorado
-$75K
2
VF
Virtu Financial
New York
-$67K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$41K
4
Goldman Sachs
Goldman Sachs
New York
-$22K
5
TSS
Two Sigma Securities
New York
-$22K

MITO Hedge Fund Activity: Q1 2021 in Review

13 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Stealth BioTherapeutics Corp. ADS (MITO) for Q1 2021, worth a combined $3.9M — up 167% from $1.46M a quarter earlier.

Fund positioning in MITO was balanced in Q1 2021: 5 funds opened new positions, 5 closed out, 6 added to existing stakes and 0 trimmed.

The largest buyer was Ikarian Capital, adding an estimated $1.29M. The largest seller was Mercer Global Advisors, exiting entirely with an estimated $75K sold.

  • 13 institutional investors held Stealth BioTherapeutics Corp. ADS (MITO) as of Q1 2021, unchanged from Q4 2020.
  • Funds reported $3.9M of Stealth BioTherapeutics Corp. ADS stock for Q1 2021, up 167% quarter-over-quarter.
  • 5 funds opened new Stealth BioTherapeutics Corp. ADS positions in Q1 2021 and 5 closed out, a net change of 0 holders.
  • The largest Stealth BioTherapeutics Corp. ADS buyer in Q1 2021 was Ikarian Capital, an estimated $1.29M added.
  • The largest Stealth BioTherapeutics Corp. ADS seller in Q1 2021 was Mercer Global Advisors, an estimated $75K sold.

Based on aggregated 13F filings for Q1 2021.